|Bid||2.16 x 1800|
|Ask||3.23 x 3200|
|Day's Range||2.2200 - 2.3605|
|52 Week Range||2.0700 - 4.2500|
|Beta (3Y Monthly)||1.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2018 - Nov 19, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.55|
EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today that warrants for 1.5 million ordinary shares in the form of American Depository Shares (ADSs) expired on November 29, 2018.
LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper.
Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea.
LYON, France, November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the.
OCTOBER 24, 2018 - Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day - October 25, 2018 -- at Jewish General Hospital, a McGill University teaching hospital, where they will learn to perform a more precise outpatient prostate procedure called high intensity focused ultrasound (HIFU). HIFU makes it possible to ablate diseased prostate tissue without the need to remove the prostate or damage critical structures that help control urinary and sexual function. The doctors will assist in performing HIFU on three different patients, using Focal One, the next generation HIFU system which received FDA clearance in the U.S. in June 2018. Focal One fuses MRI and biopsy data with real-time ultrasound imaging.
While small-cap stocks, such as EDAP TMS SA (NASDAQ:EDAP) with its market cap of US$78m, are popular for their explosive growth, investors should also be aware of their balance sheet Read More...
EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today that warrants for approximately 3.3 million ordinary shares in the form of American Depository Shares (ADSs) expired on October 14, 2018. On April 14, 2016, pursuant to a securities purchase agreement dated April 7, 2016, the Company issued 3,283,284 ordinary shares in the form of ADSs to certain institutional investors in a registered direct placement, at a price of $3.50 per share, with warrants attached that allow investors to purchase up to 3,283,284 shares in the form of ADSs, at an exercise price of $4.50 per share.
The Albert Einstein Hospital, as a reference cancer center, sought this technology in order to offer its patients an individualized approach, making available all the possibilities of treatment of localized prostate cancer, with the objective of achieving the best possible outcomes according to the characteristics of the patient and tumor.
LYON, France, September 26, 2018 - EDAP TMS (EDAP) today announced the results of a study conducted at Houston Methodist Medical Center in Houston, TX that showed High Intensity Focused Ultrasound (HIFU) to be safe and effective, with oncologic control for prostate cancer patients. The study will be formally presented at a sectional meeting of the American Urological Association in Nashville, TN on September 26, 2018. Researchers evaluated the clinical outcomes from July 2016 to July 2018 on 24 patients who had a whole-gland HIFU procedure using the EDAP Ablatherm Robotic HIFU machine.
EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced the installation of the first Focal One device in South Korea, at the renowned Seoul National University Bundang Hospital ("SNUBH"). Dr. Hakmin Lee, Urologist in SNUBH commented: "We are very happy to adopt the first "Focal One" device in our institution and we also believe that Korean patients will significantly benefit from the upcoming HIFU procedures. From our initial experiences, the Focal One device showed extraordinary performance which was definitely beyond our expectations.
NEW YORK, NY / ACCESSWIRE / August 30, 2018 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 30, 2018 at 8:30 AM Eastern ...
WallStEquities.com revisits the Medical Appliances and Equipment space, which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Under evaluation this morning are these four stocks: EDAP TMS S.A. (NASDAQ: EDAP), PAVmed Inc. (NASDAQ: PAVM), Amedica Corp. (NASDAQ: AMDA), and Avinger Inc. (NASDAQ: AVGR).
LONDON, UK / ACCESSWIRE / June 14, 2018 / If you want access to our free research report on RTI Surgical, Inc. (NASDAQ: RTIX), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=RTIX as the Company's latest news hit the wire. On June 12, 2018, the Company announced that it has commercially launched Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology. The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures at one or two adjoining levels in patients with degenerative disc disease.
Remote patient monitoring, through smaller cheaper technology, is transforming medical care in the U.S. Cardiac care is a major beneficiary, and now major government agencies are signalling that this sector could be a top priority in the coming years. New medical device from Biotricity (BTCY) could shake up a handful of existing companies in cardiac remote monitoring, as their new device has some clear improvements over older technology. With revenue and new product announcements this year, BTCY could move significantly higher in 2018 and 2019.
U.S. stock indexes were lower on Friday as shares of Apple and its suppliers fell, following a report that the iPhone maker was planning to produce fewer phones this year. Apple Inc was down 1.6 percent after a newspaper report said the company had asked its supply chain to manufacture about 20 percent fewer components for iPhones in the latter half of 2018. Investors were also cautious ahead of a contentious G7 summit in Canada, with U.S. President Donald Trump lashing out at Canada and the European Union on Friday, raising the specter of a trade war.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Stocks hitting 52-week highs on June 7) Baxter International Inc (NYSE: BAX ) Bio-Rad Laboratories, ...
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Docusign Inc (NASDAQ: DOCU ) stock was trading higher ...
When EDAP TMS SA. (NASDAQ:EDAP) announced its most recent earnings (31 December 2017), I did two things: looked at its past earnings track record, then look at what is happeningRead More...
NEW YORK, NY / ACCESSWIRE / May 15, 2018 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 15, 2018 at 8:30 AM Eastern Time. ...